Antifungal Resistance
Antimicrobial resistance (AMR) continues to pose a serious threat to human health, as well as the health of animals and the environment. This week is World AMR Awareness Week, a global campaign run by…
Read moreClinical Articles
HPS Pharmacies prides itself on providing innovative and informative support to assist in the diverse range of issues health professionals face on a day-to-day basis, and to facilitate the distribution of this information for a variety of sectors within the healthcare industry.
HPS’ clinical articles are written by HPS Pharmacies’ experienced and knowledgeable staff and are peer-reviewed by specialist leaders in their field to ensure the accuracy of the information provided. The resourceful and diverse range of articles play an integral role in keeping all health professionals up-to-date with the happenings throughout the industry on a regular basis.
Evidence-based Non-drug Treatments in Dementia – Reminiscence Therapy
Dementia is a progressive disease, with non-cognitive symptoms emerging at a far greater rate as the person ages. Dementia causes significant emotional, psychological and structural turmoil for all involved, with a projected total of …
Read more
An Overview of Fungi
The fungal kingdom encompasses a range of diverse species, including moulds, yeasts, and mushrooms. It has been estimated that there are between 2.2 and 3.8 million species of fungi. All fungi are eukaryotic organisms…
Read more
Lower Urinary Tract Symptoms in Men
Lower urinary tract symptoms (LUTS) are common in men and increase with age. These symptoms can be classified as either voiding symptoms or storage symptoms. Voiding symptoms are often related to prostate enlargement….
Read more
Weight Loss Medications
Overweight and obesity are the second leading risk factors for ill health and death in Australia, second only to tobacco use. Excess weight is linked to 30 diseases, including some cancers, cardiovascular disease, and…
Read more
Revised Hip Fracture Clinical Care Standard
The Australian Commission on Safety and Quality in Healthcare (ACSQHC) has just released the revised Hip Fracture Clinical Care Standard (2023). This publication provides guidance on pain management, time to surgery, mobilisation, and prevention…
Read moreNovember 2023
Antifungal Resistance (Nov. 24 2023)
Evidence-based Non-drug Treatments in Dementia – Reminiscence Therapy (Nov. 10 2023)
October 2023
An Overview of Fungi (Oct. 27 2023)
Lower Urinary Tract Symptoms in Men (Oct. 13 2023)
September 2023
Weight Loss Medications (Sep. 29 2023)
Revised Hip Fracture Clinical Care Standard (Sep. 15 2023)
Antibiotic Use in the Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (Sep. 01 2023)
August 2023
Erythropoietin Resistance (Aug. 18 2023)
Amiodarone-induced Thyroid Disorders (Aug. 04 2023)
July 2023
Biological Therapies for Rheumatoid Arthritis (Jul. 21 2023)
Mineralocorticoid Receptor Antagonists (Jul. 07 2023)
June 2023
Neo-Adjuvant Treatment of Melanoma and Directed Therapy from the PRADO Trial (Jun. 23 2023)
Anticoagulant-Related Nephropathy (Jun. 09 2023)
May 2023
Sepsis (May. 26 2023)
Patient Self-Management (May. 12 2023)
April 2023
The Role of the Pharmacist in Survivorship Care (Apr. 28 2023)
Recurrent Urinary Tract Infections in Women (Apr. 14 2023)
March 2023
Enerzair® Breezhaler® (Mar. 31 2023)
Tirzepatide: a New Treatment for Type 2 Diabetes and Weight Loss (Mar. 17 2023)
Vedolizumab and Ustekinumab for the Treatment of Crohn’s Disease (Mar. 03 2023)
February 2023
Wernicke-Korsakoff Syndrome (Feb. 17 2023)
Gestational Diabetes (Feb. 03 2023)
January 2023
Glucagon-like Peptide-1 Receptor Agonists (Jan. 20 2023)
The Clinical Merits Associated with Utilising a Prescribing Pharmacist (Jan. 06 2023)
December 2022
Improving Medication Use at Transitions of Care (Dec. 23 2022)
Vericiguat for Heart Failure (Dec. 09 2022)
November 2022
Probiotics for Preterm Infants (Nov. 25 2022)
Updated Recommendations for the Dosing of Anticancer Drugs in Kidney Dysfunction (Nov. 11 2022)
October 2022
Solid Oral Dose Forms and Swallowing Difficulties (Oct. 28 2022)
Vancomycin Use in Arthroplasty Patients (Oct. 14 2022)
September 2022
Drug Holidays from Bisphosphonates (Sep. 30 2022)
Iron Deficiency Anaemia (Sep. 16 2022)
Drug-induced QT Interval Prolongation (Sep. 02 2022)
August 2022
Monkeypox in Australia (Aug. 19 2022)
Anticholinergic Burden (Aug. 05 2022)
July 2022
June 2022
May 2022
April 2022
New Therapy for Cystic Fibrosis (Apr. 29 2022)
Seasonal Influenza Vaccination (Apr. 14 2022)
Paroxysmal Nocturnal Haemoglobinuria (Apr. 01 2022)
March 2022
Aged Care and Chemical Restraint (Mar. 18 2022)
Molnupiravir for COVID-19 (Mar. 04 2022)
February 2022
SGLT2 Inhibitors for Heart Failure (Feb. 18 2022)
COVID-19 Treatment Options (Feb. 04 2022)
January 2022
What is Cancer Survivorship Care? (Jan. 21 2022)
December 2021
Managing the Side Effects of Chemotherapy (Dec. 31 2021)
COVID-19 Vaccine Boosters (Dec. 17 2021)
Glucagon-like Peptide-1 Analogues (Dec. 03 2021)
November 2021
Antimicrobial Awareness Week (Nov. 18 2021)
Restless Legs Syndrome (Nov. 05 2021)
October 2021
Medication Interactions with Food (Oct. 21 2021)
Revised Delirium Clinical Care Standard (Oct. 08 2021)
September 2021
Hepatitis B Reactivation (Sep. 23 2021)
Antimicrobial resistance: The need for stewardship (Sep. 08 2021)
August 2021
Cannabis (Aug. 26 2021)
Melanoma – An Update in Treatment Strategies (Aug. 13 2021)
July 2021
New Labelling Standard (Jul. 30 2021)
Prevention of Shingles (Jul. 16 2021)
Melatonin down scheduling: a brief update (Jul. 01 2021)
June 2021
Topical treatment in psoriasis (Jun. 17 2021)
Progress of Cervical Cancer Elimination (Jun. 04 2021)
May 2021
New Action Plan for Pain Management (May. 21 2021)
Thyroid Awareness Month (May. 06 2021)
April 2021
Influenza Vaccines (Apr. 23 2021)
Treatment of Eosinophilic Oesophagitis (Apr. 09 2021)
March 2021
February 2021
Hospital-initiated Medication Reviews (Feb. 26 2021)
Boxed Warnings for Gabapentinoids (Feb. 10 2021)
January 2021
COVID-19 Vaccines (Jan. 28 2021)
Updates to the Poisons Standard (Jan. 15 2021)
December 2020
Active Ingredient Prescribing (Dec. 23 2020)
New Digital Mental Health Standards (Dec. 18 2020)
Approval of New Prescription Medications (Dec. 04 2020)
November 2020
Antimicrobial Resistance (Nov. 20 2020)
Vaccines and Cold Chain (Nov. 06 2020)
October 2020
Darolutamide (Nubeqa®) in Prostate Cancer (Oct. 22 2020)
Drugs in Sport (Oct. 09 2020)
September 2020
Treatment of Infantile Haemangioma (Sep. 25 2020)
Abemaciclib for Breast Cancer (Sep. 11 2020)
August 2020
Primary Cutaneous T-cell Lymphoma (Aug. 28 2020)
Gliflozins and Heart Failure (Aug. 12 2020)
July 2020
Remdesivir – an emerging treatment for COVID-19 patients. (Jul. 31 2020)
Safe Injection Practices (Jul. 17 2020)
Diabetes and Insulin (Jul. 02 2020)
June 2020
Hydroxychloroquine as triple therapy in COVID-19 patients (Jun. 16 2020)
Tocilizumab, COVID-19 and the cytokine storm (Jun. 03 2020)
May 2020
Colchicine use in Acute Myocardial Infarction (May. 20 2020)
Changes to Opioid PBS Listings (May. 06 2020)
April 2020
Coronavirus Disease (Apr. 22 2020)
Risk of Viral Transmission with Nebulised Medication Delivery (Apr. 09 2020)
March 2020
February 2020
Xerostomia (Feb. 27 2020)
Monoclonal Antibodies for Migraine (Feb. 13 2020)
January 2020
Changes to Neural Connector Devices (Jan. 30 2020)
Venetoclax (Jan. 16 2020)
Biosimilars in Oncology (Jan. 03 2020)
December 2019
November 2019
Prescription Opioid Changes (Nov. 22 2019)
Diabetes Medications in the Peri-Operative Period (Nov. 08 2019)
October 2019
Lamotrigine Dose Escalation (Oct. 25 2019)
Wilson Disease (Oct. 11 2019)
September 2019
Parkinson’s Disease and Hospitalisation (Sep. 27 2019)
Understanding Clinical Trials (Sep. 13 2019)
August 2019
Short-Course Oxycodone Packs (Aug. 30 2019)
Tafenoquine: A Novel Anti-Malarial (Aug. 16 2019)
Medicinal Marijuana? (Aug. 02 2019)
July 2019
Primary Prevention: a Low-Dose Aspirin Story (Jul. 19 2019)
Hand-Foot Syndrome (Jul. 08 2019)
June 2019
Low Dose Methotrexate for Rheumatoid Arthritis (Jun. 21 2019)
Introduction to the storage of medications in a private hospital setting (Jun. 07 2019)
May 2019
Lactulose for Hepatic Encephalopathy (May. 24 2019)
Proton Pump Inhibitor Restrictions (May. 10 2019)
April 2019
Prevention of Recurrent Clostridium difficile Infection (Apr. 25 2019)
Updates to the Australian Asthma Handbook (Apr. 12 2019)
March 2019
Heparins (Mar. 29 2019)
Safety and Quality Standards for Mental Health (Mar. 15 2019)
Potentially Harmful Medication Use in the Elderly (Mar. 01 2019)
February 2019
Animal-Assisted Therapy for Dementia (Feb. 15 2019)
Augmented Renal Clearance (Feb. 01 2019)
January 2019
Biofilms (Jan. 18 2019)
Medications and Sun Exposure (Jan. 04 2019)